| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.17B | 17.52B | 13.59B | 10.75B | 7.44B | 6.20B |
| Gross Profit | 2.72B | 3.30B | 4.44B | 5.51B | 3.36B | 2.03B |
| EBITDA | 6.98B | 7.11B | 3.00B | 7.75B | 5.73B | 4.14B |
| Net Income | 1.29B | 1.56B | -1.71B | 2.60B | 2.00B | 864.18M |
Balance Sheet | ||||||
| Total Assets | 25.03B | 26.12B | 25.83B | 27.42B | 25.03B | 24.94B |
| Cash, Cash Equivalents and Short-Term Investments | 2.00B | 3.32B | 3.33B | 3.17B | 3.26B | 2.77B |
| Total Debt | 559.89M | 530.05M | 3.10B | 3.81B | 4.94B | 5.67B |
| Total Liabilities | 12.23B | 12.83B | 12.99B | 11.61B | 10.79B | 12.03B |
| Stockholders Equity | 12.80B | 13.29B | 12.83B | 15.80B | 14.23B | 12.91B |
Cash Flow | ||||||
| Free Cash Flow | 562.63M | 1.13B | 648.58M | 2.10B | 1.55B | 17.19M |
| Operating Cash Flow | 5.89B | 7.43B | 7.33B | 7.82B | 4.28B | 1.91B |
| Investing Cash Flow | -5.50B | -6.23B | -6.54B | -5.71B | -2.49B | -2.18B |
| Financing Cash Flow | -2.80B | -1.59B | -638.13M | -2.07B | -1.45B | -94.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$14.29B | 4.51 | 9.87% | 20.93% | 8.65% | ― | |
71 Outperform | HK$62.86B | 11.10 | 7.88% | 4.58% | 4.37% | 0.58% | |
68 Neutral | HK$1.33T | 7.65 | 16.65% | 6.76% | -9.81% | -8.84% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | HK$70.14B | 7.80 | 8.45% | 3.59% | 2.58% | 7.10% | |
56 Neutral | HK$30.55B | 51.87 | 10.74% | 0.31% | -26.37% | -62.54% | |
56 Neutral | HK$49.18B | -287.32 | 7.10% | ― | 1.90% | -8.51% |